| Bacillus subtilis (strain 168) |
DNA polymerase III |
Potency |
1500.3 |
nM |
None |
| Bos taurus |
Calf thymus DNA |
C50 |
0.021 |
uM |
10.1021/jm970114u |
| Bos taurus |
Calf thymus DNA |
C50 |
0.037 |
uM |
10.1021/jm011004x |
| Bos taurus |
Calf thymus DNA |
C50 |
0.037 |
uM |
10.1021/jm970114u |
| Bos taurus |
Calf thymus DNA |
Delta Tm |
15.9 |
degrees C |
10.1016/j.bmcl.2004.07.036 |
| Bos taurus |
Calf thymus DNA |
EC50 |
400.0 |
nM |
10.1016/s0960-894x(02)00218-4 |
| Bos taurus |
Calf thymus DNA |
EC50 |
3400.0 |
nM |
10.1021/jm011117g |
| Bos taurus |
Calf thymus DNA |
Ka |
1.0 |
10'6/M |
10.1021/acs.jmedchem.5b00859 |
| Bos taurus |
Calf thymus DNA |
K app |
1.9e-06 |
None |
10.1021/jm9805586 |
| Bos taurus |
Calf thymus DNA |
K app |
34.0 |
10e-7/M |
10.1021/jm049706k |
| Bos taurus |
Calf thymus DNA |
Q |
0.34 |
uM |
10.1021/jm970114u |
| Bos taurus |
Calf thymus DNA |
Ratio |
0.0 |
None |
10.1016/j.bmc.2010.04.074 |
| Bos taurus |
Calf thymus DNA |
Ratio |
0.0 |
None |
10.1016/j.ejmech.2010.08.061 |
| Bos taurus |
DNA |
Activity |
nan |
None |
10.1016/j.bmcl.2013.01.022 |
| Bos taurus |
DNA |
Delta Tm |
18.4 |
degrees C |
10.1016/j.bmc.2008.01.033 |
| Bos taurus |
DNA |
Delta Tm |
25.3 |
degrees C |
10.1016/j.bmc.2007.10.012 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cricetulus griseus |
XRS6 |
IC50 |
10.0 |
nM |
10.1021/jm00022a016 |
| Drosophila melanogaster |
DNA topoisomerase II |
IC90 |
56000.0 |
nM |
10.1021/jm00022a016 |
| Equus caballus |
Ferritin light chain |
Potency |
11220.2 |
nM |
None |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1016/j.bmc.2009.05.070 |
| Escherichia coli |
Escherichia coli |
MIC |
8.4 |
ug.mL-1 |
10.1016/j.bmc.2009.05.070 |
| Homo sapiens |
2008 |
IC50 |
7.8 |
nM |
10.1021/acs.jmedchem.9b00963 |
| Homo sapiens |
786-0 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
7,8-dihydro-8-oxoguanine triphosphatase |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.9b00420 |
| Homo sapiens |
78 kDa glucose-regulated protein |
Potency |
2328.1 |
nM |
None |
| Homo sapiens |
A2780 |
IC50 |
0.55 |
nM |
10.1021/jm970114u |
| Homo sapiens |
A2780 |
IC50 |
0.55 |
nM |
10.1021/jm9801105 |
| Homo sapiens |
A2780 |
IC50 |
6.11 |
nM |
10.1021/jm980682p |
| Homo sapiens |
A2780 |
IC50 |
25.1 |
nM |
10.1021/jm980682p |
| Homo sapiens |
A2780 |
IC50 |
5500.0 |
nM |
10.1016/0960-894X(96)00130-8 |
| Homo sapiens |
A-375 |
IC50 |
26.0 |
nM |
10.1021/jm00003a015 |
| Homo sapiens |
A-375 |
IC50 |
111.5 |
nM |
10.1016/j.ejmech.2019.03.051 |
| Homo sapiens |
A498 |
GI50 |
112.46 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
8300.0 |
nM |
10.1016/j.bmcl.2010.01.096 |
| Homo sapiens |
A549 |
IC50 |
0.036 |
nM |
10.1021/acs.jnatprod.8b00482 |
| Homo sapiens |
A549 |
IC50 |
3.1 |
nM |
10.1021/jm950742g |
| Homo sapiens |
A549 |
IC50 |
3.1 |
nM |
10.1021/jm960623g |
| Homo sapiens |
A549 |
IC50 |
15.7 |
ug.mL-1 |
10.1016/j.ejmech.2015.11.002 |
| Homo sapiens |
A549 |
IC50 |
25.3 |
ug.mL-1 |
10.1007/s00044-012-0325-2 |
| Homo sapiens |
A549 |
IC50 |
70.0 |
nM |
10.1016/j.bmcl.2022.128919 |
| Homo sapiens |
A549 |
IC50 |
300.0 |
nM |
10.1016/s0960-894x(02)00218-4 |
| Homo sapiens |
A549 |
IC50 |
300.0 |
nM |
10.1021/jm011117g |
| Homo sapiens |
A549 |
IC50 |
7250.0 |
nM |
10.1016/j.ejmech.2019.01.028 |
| Homo sapiens |
A549 |
IC50 |
7800.0 |
nM |
10.1016/j.bmc.2011.03.009 |
| Homo sapiens |
A549 |
IC50 |
7800.0 |
nM |
10.1016/j.bmcl.2011.03.089 |
| Homo sapiens |
A549 |
IC50 |
7830.0 |
nM |
10.1016/j.bmcl.2011.01.072 |
| Homo sapiens |
A549 |
IC50 |
8000.0 |
nM |
10.1016/j.bmcl.2009.06.097 |
| Homo sapiens |
A549 |
Inhibition |
67.3 |
% |
10.1007/s00044-012-0325-2 |
| Homo sapiens |
A549 |
Inhibition |
nan |
% |
10.1007/s00044-012-0325-2 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
ACHN |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
7121.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Amyloid-beta A4 protein |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
2993.5 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
4609.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
32629.4 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
50.0 |
% |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
100.0 |
% |
10.1016/j.bmc.2007.10.006 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
439.2 |
% |
10.1016/j.bmc.2007.10.006 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1002/ijc.11484 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1124/mol.63.1.65 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1124/mol.64.3.610 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1124/mol.64.6.1452 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
10.1242/jcs.113.11.2011 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
903.8 |
nM |
10.1021/acs.jmedchem.9b00963 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Kact |
7.0 |
uM |
10.1006/bbrc.2001.5130 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Ratio IC50 |
15.33 |
None |
10.1016/j.bmcl.2011.08.070 |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Bel-7402 |
IC50 |
116.6 |
nM |
10.1016/j.ejmech.2019.03.051 |
| Homo sapiens |
Bel-7402 |
IC90 |
1300.0 |
nM |
10.1016/j.ejmech.2019.03.051 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bloom syndrome protein |
Potency |
1358.0 |
nM |
None |
| Homo sapiens |
Bloom syndrome protein |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
BT-549 |
GI50 |
104.23 |
nM |
None |
| Homo sapiens |
Caco-2 |
Activity |
0.91 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
2.49 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
3.34 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
6.07 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
15.4 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
19.4 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
22.1 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
27.8 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
36.0 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
42.0 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
50.7 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
73.6 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
Activity |
nan |
None |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
IC50 |
1400.0 |
nM |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Caco-2 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
CAKI-1 |
GI50 |
13.37 |
nM |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
175.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Casein kinase 2 |
IC50 |
660.0 |
nM |
10.1021/jm400045y |
| Homo sapiens |
Casein kinase II alpha (prime) |
Activity |
81.8 |
% |
10.1021/jm400045y |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCD 19Lu |
IC50 |
160.0 |
nM |
10.1039/C6MD00643D |
| Homo sapiens |
CCRF-CEM |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
CCRF-CEM |
IC50 |
36.0 |
nM |
10.1021/jm300515q |
| Homo sapiens |
CCRF-CEM |
IC50 |
3600.0 |
nM |
10.1021/jm030253d |
| Homo sapiens |
CCRF-CEM |
Ratio IC50 |
2.0 |
None |
10.1021/jm200764t |
| Homo sapiens |
CCRF-CEM |
Ratio IC50 |
2.3 |
None |
10.1021/jm300515q |
| Homo sapiens |
CCRF-CEM |
Ratio IC50 |
3.0 |
None |
10.1021/jm300515q |
| Homo sapiens |
CCRF-CEM |
Ratio IC50 |
30.0 |
None |
10.1021/jm300515q |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
23934.1 |
nM |
None |
| Homo sapiens |
CH1 |
IC50 |
2.65 |
nM |
10.1021/jm970114u |
| Homo sapiens |
CH1 |
IC50 |
2.65 |
nM |
10.1021/jm9801105 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
COLO 205 |
GI50 |
134.59 |
nM |
None |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
1300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
76300.0 |
nM |
10.1021/jm049934e |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Daudi |
IC50 |
5.0 |
nM |
10.1016/j.bmcl.2015.04.093 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA polymerase eta |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
DNA polymerase eta |
Potency |
19011.5 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
2993.5 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
1337.1 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
2377.8 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
2667.9 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
DNA repair protein RAD52 homolog |
AC50 |
244.0 |
nM |
None |
| Homo sapiens |
DNA topoisomerase II |
IC90 |
1100.0 |
nM |
10.1021/jm00022a016 |
| Homo sapiens |
DNA topoisomerase II |
IC90 |
1100.0 |
nM |
10.1021/jm00048a017 |
| Homo sapiens |
DNA topoisomerase II alpha |
IC50 |
5300.0 |
nM |
10.1016/j.bmc.2008.01.033 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
Activity |
66.0 |
% |
10.1021/jm400813y |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Inhibition |
29.0 |
% |
10.1021/jm400813y |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
5173.5 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
Activity |
-0.4 |
% |
10.1021/jm400813y |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Inhibition |
81.0 |
% |
10.1021/jm400813y |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
29999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
DU-145 |
GI50 |
22.49 |
nM |
None |
| Homo sapiens |
DU-145 |
IC50 |
5.6 |
nM |
10.1021/jm980682p |
| Homo sapiens |
EKVX |
GI50 |
1279.38 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
5385.9 |
nM |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
23340.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
1345.9 |
nM |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
2993.5 |
nM |
None |
| Homo sapiens |
G-361 |
IC50 |
0.65 |
nM |
10.1021/jm970114u |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Glycoprotein hormones alpha chain |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Guanine nucleotide-binding protein G(s), subunit alpha |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
HaCaT |
IC50 |
3900.0 |
nM |
10.1021/acs.jnatprod.5b00768 |
| Homo sapiens |
HCC 2998 |
GI50 |
87.7 |
nM |
None |
| Homo sapiens |
HCC78 |
Activity |
0.048 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
0.076 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
0.089 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
16.4 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
16.9 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
17.2 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
18.6 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
18.7 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
19.7 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
63.8 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
66.6 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
66.7 |
% |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
Activity |
nan |
None |
10.1039/C6MD00643D |
| Homo sapiens |
HCC78 |
IC50 |
13.83 |
nM |
10.1039/C6MD00643D |
| Homo sapiens |
HCT-116 |
GI |
53.22 |
% |
10.1007/s00044-013-0805-z |
| Homo sapiens |
HCT-116 |
GI50 |
37.33 |
nM |
None |
| Homo sapiens |
HCT-116 |
IC50 |
5.8 |
nM |
10.1021/jm049706k |
| Homo sapiens |
HCT-116 |
IC50 |
22.0 |
nM |
10.1016/j.bmcl.2011.03.021 |
| Homo sapiens |
HCT-116 |
IC50 |
25.0 |
nM |
10.1016/j.bmcl.2015.04.093 |
| Homo sapiens |
HCT-116 |
IC50 |
1610.0 |
nM |
10.1016/j.ejmech.2018.01.074 |
| Homo sapiens |
HCT-116 |
IC50 |
3960.0 |
nM |
10.1016/j.bmcl.2010.09.074 |
| Homo sapiens |
HCT-116 |
IC50 |
7200.0 |
nM |
10.1016/j.bmc.2011.03.009 |
| Homo sapiens |
HCT-116 |
IC50 |
7200.0 |
nM |
10.1016/j.bmcl.2011.03.089 |
| Homo sapiens |
HCT-116 |
IC50 |
nan |
nM |
10.1021/jm00048a017 |
| Homo sapiens |
HCT-15 |
GI50 |
133.35 |
nM |
None |
| Homo sapiens |
HEK293 |
Activity |
nan |
None |
None |
| Homo sapiens |
HEK293 |
IC50 |
10.0 |
nM |
10.1021/jm401879z |
| Homo sapiens |
HEK293 |
IC50 |
11.7 |
nM |
10.1021/acs.jmedchem.9b00963 |
| Homo sapiens |
HEK293 |
IC50 |
26.6 |
nM |
10.1021/jm401879z |
| Homo sapiens |
HEK293 |
IG50 |
0.009 |
uM |
10.1021/jm500943z |
| Homo sapiens |
HEK293 |
Potency |
65.1 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
501.2 |
nM |
None |
| Homo sapiens |
HeLa |
AC50 |
4075.0 |
nM |
None |
| Homo sapiens |
HeLa |
Activity |
1.0 |
uM |
10.1021/acs.jmedchem.1c00154 |
| Homo sapiens |
HeLa |
EC50 |
0.55 |
ug.mL-1 |
10.1021/jm00118a015 |
| Homo sapiens |
HeLa |
IC50 |
40.0 |
nM |
10.1016/j.bmcl.2022.128919 |
| Homo sapiens |
HeLa |
IC50 |
44.0 |
nM |
10.1016/j.bmcl.2015.04.093 |
| Homo sapiens |
HeLa |
IC50 |
100.0 |
nM |
10.1021/jm800160v |
| Homo sapiens |
HeLa |
IC50 |
2350.0 |
nM |
10.1016/j.ejmech.2018.01.074 |
| Homo sapiens |
HeLa |
ID50 |
2.77 |
uM |
10.1016/S0960-894X(00)80385-6 |
| Homo sapiens |
HepG2 |
GI |
62.73 |
% |
10.1007/s00044-013-0805-z |
| Homo sapiens |
HepG2 |
IC50 |
11050.0 |
nM |
10.1016/j.bmc.2014.03.045 |
| Homo sapiens |
HepG2 |
IC50 |
15330.0 |
nM |
10.1016/j.bmc.2020.115868 |
| Homo sapiens |
HepG2 |
IC50 |
18600.0 |
nM |
10.1016/j.ejmech.2018.01.074 |
| Homo sapiens |
HepG2 |
IC50 relative |
800.0 |
nM |
10.6019/EOS300108 |
| Homo sapiens |
HepG2 |
Inhibition |
41.2 |
% |
10.1016/j.ejmech.2016.04.031 |
| Homo sapiens |
HepG2 |
Inhibition |
78.6 |
% |
10.1016/j.ejmech.2016.04.031 |
| Homo sapiens |
HepG2 |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
41269.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
3584.9 |
nM |
None |
| Homo sapiens |
HERG |
Ki |
2937.0 |
nM |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
11727.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
15.97 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
28.59 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
8436.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase MLL |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase NSD2 |
AC50 |
2340.0 |
nM |
None |
| Homo sapiens |
HL-60 |
GI50 |
0.192 |
ug.mL-1 |
10.1021/jm9005059 |
| Homo sapiens |
HL-60 |
GI50 |
0.33 |
nM |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
HL-60 |
GI50 |
10.0 |
nM |
10.1016/j.bmc.2007.03.067 |
| Homo sapiens |
HL-60 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
HL-60 |
GI50 |
7800.0 |
nM |
10.1016/j.bmcl.2010.01.096 |
| Homo sapiens |
HL-60 |
IC50 |
0.024 |
nM |
10.1021/acs.jnatprod.8b00482 |
| Homo sapiens |
HL-60 |
IC50 |
0.29 |
ug.mL-1 |
10.1021/np9903705 |
| Homo sapiens |
HL-60 |
IC50 |
0.81 |
nM |
10.1021/jm980682p |
| Homo sapiens |
HL-60 |
IC50 |
2.5 |
nM |
10.1016/j.bmcl.2012.08.032 |
| Homo sapiens |
HL-60 |
IC50 |
4.0 |
nM |
10.1016/j.bmcl.2018.06.042 |
| Homo sapiens |
HL-60 |
IC50 |
4.0 |
nM |
10.1016/j.ejmech.2017.03.028 |
| Homo sapiens |
HL-60 |
IC50 |
16.0 |
nM |
10.1021/jm300515q |
| Homo sapiens |
HL-60 |
IC50 |
63.0 |
nM |
10.1016/j.bmc.2010.08.025 |
| Homo sapiens |
HL-60 |
IC50 |
63.0 |
nM |
10.1016/j.bmcl.2011.02.106 |
| Homo sapiens |
HL-60 |
IC50 |
63.0 |
nM |
10.1021/jm800017u |
| Homo sapiens |
HL-60 |
IC50 |
3350.0 |
nM |
10.1021/jm980324m |
| Homo sapiens |
HL-60 |
IC50 |
6300.0 |
nM |
10.1016/j.bmcl.2009.06.097 |
| Homo sapiens |
HL-60 |
IC50 |
6800.0 |
nM |
10.1016/j.bmcl.2009.10.110 |
| Homo sapiens |
HL-60 |
IC50 |
7500.0 |
nM |
10.1016/j.bmcl.2010.09.074 |
| Homo sapiens |
HL-60 |
IC50 |
7900.0 |
nM |
10.1016/j.bmc.2011.03.009 |
| Homo sapiens |
HL-60 |
IC50 |
8100.0 |
nM |
10.1016/j.bmcl.2011.01.072 |
| Homo sapiens |
HL-60 |
IC50 |
8200.0 |
nM |
10.1016/j.bmcl.2011.03.089 |
| Homo sapiens |
HL-60 |
IC90 |
8030.0 |
nM |
10.1021/jm980324m |
| Homo sapiens |
HL-60 |
ID50 |
0.09 |
uM |
10.1016/S0960-894X(00)80385-6 |
| Homo sapiens |
HL-60 |
Ratio EC50 |
26.0 |
None |
None |
| Homo sapiens |
HL-60 |
RatioGI50 |
13.0 |
None |
10.1016/j.bmc.2007.03.067 |
| Homo sapiens |
HL-60 |
RatioGI50 |
23.0 |
None |
10.1021/jm9005059 |
| Homo sapiens |
HL-60 |
RatioGI50 |
79.0 |
None |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
HL-60 |
Ratio IC50 |
2.4 |
None |
10.1021/jm300515q |
| Homo sapiens |
HL-60 |
Ratio IC50 |
7.5 |
None |
10.1021/jm200764t |
| Homo sapiens |
HL-60 |
Ratio IC50 |
10.0 |
None |
10.1021/jm300515q |
| Homo sapiens |
HL-60 |
Ratio IC50 |
20.0 |
None |
10.1021/jm300515q |
| Homo sapiens |
HL-60 |
Ratio IC50 |
24.0 |
None |
10.1016/j.bmc.2010.08.025 |
| Homo sapiens |
HL-60 |
Ratio IC50 |
24.0 |
None |
10.1016/j.bmcl.2011.02.106 |
| Homo sapiens |
HL-60 |
Ratio IC50 |
24.1 |
None |
None |
| Homo sapiens |
HL-60 |
Ratio IC50 |
224.4 |
None |
10.1016/j.bmcl.2012.08.032 |
| Homo sapiens |
HL60/MX2 |
IC50 |
148.0 |
nM |
10.1016/j.bmcl.2018.06.042 |
| Homo sapiens |
HL60/MX2 |
IC50 |
148.0 |
nM |
10.1016/j.ejmech.2017.03.028 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
CL |
7.9 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.5 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fabs |
85.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
Homo sapiens |
IC50 |
0.0055 |
ug.mL-1 |
10.1021/jm00112a009 |
| Homo sapiens |
Homo sapiens |
IC50 |
0.274 |
ug.mL-1 |
10.1021/jm00112a009 |
| Homo sapiens |
Homo sapiens |
IC50 |
10.0 |
nM |
10.1021/jm030820x |
| Homo sapiens |
Homo sapiens |
ID50 |
2.7e-07 |
M |
10.1021/jm00067a005 |
| Homo sapiens |
HOP-62 |
GI50 |
12.39 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
35.48 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
28.44 |
nM |
None |
| Homo sapiens |
HT-1080 |
IC50 |
66.0 |
nM |
10.1021/jm00003a015 |
| Homo sapiens |
HT-29 |
GI50 |
135.21 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
8900.0 |
nM |
10.1016/j.bmcl.2010.01.096 |
| Homo sapiens |
HT-29 |
IC50 |
10.0 |
nM |
10.1021/jm010917o |
| Homo sapiens |
HT-29 |
IC50 |
10.0 |
nM |
10.1021/jm011004x |
| Homo sapiens |
HT-29 |
IC50 |
10.0 |
nM |
10.1021/jm049706k |
| Homo sapiens |
HT-29 |
IC50 |
10.0 |
nM |
10.1021/jm970114u |
| Homo sapiens |
HT-29 |
IC50 |
10.0 |
nM |
10.1021/jm9805586 |
| Homo sapiens |
HT-29 |
IC50 |
17.0 |
nM |
10.1021/jm00003a015 |
| Homo sapiens |
HT-29 |
IC50 |
19.6 |
nM |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
IC50 |
20.0 |
nM |
10.1016/j.bmcl.2005.07.079 |
| Homo sapiens |
HT-29 |
IC50 |
25.0 |
nM |
10.1016/j.bmcl.2006.06.074 |
| Homo sapiens |
HT-29 |
IC50 |
2025.0 |
nM |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
IC50 |
8000.0 |
nM |
10.1016/s0960-894x(02)00218-4 |
| Homo sapiens |
HT-29 |
IC50 |
8000.0 |
nM |
10.1021/jm011117g |
| Homo sapiens |
HT-29 |
IC50 |
8700.0 |
nM |
10.1016/j.bmcl.2009.06.097 |
| Homo sapiens |
HT-29 |
IC50 |
21650.0 |
nM |
10.1016/j.ejmech.2018.01.074 |
| Homo sapiens |
HT-29 |
Inhibition |
8.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
17.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
20.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
24.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
29.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
30.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
34.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
37.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
46.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
47.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Inhibition |
62.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Survival |
17.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Survival |
22.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Survival |
45.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Survival |
51.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
HT-29 |
Survival |
80.0 |
% |
10.1021/jm980682p |
| Homo sapiens |
Huntingtin |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
91.41 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Ishikawa |
IC50 |
10.0 |
nM |
10.1016/j.bmcl.2015.04.093 |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
Jurkat |
Activity |
50.0 |
% |
10.1016/j.ejmech.2017.11.063 |
| Homo sapiens |
Jurkat |
Activity |
nan |
None |
None |
| Homo sapiens |
K562 |
GI |
52.12 |
% |
10.1007/s00044-013-0805-z |
| Homo sapiens |
K562 |
GI50 |
74.13 |
nM |
None |
| Homo sapiens |
K562 |
IC50 |
0.0334 |
ug.mL-1 |
10.1021/np9903705 |
| Homo sapiens |
K562 |
IC50 |
2.0 |
ug.mL-1 |
10.1021/np0102049 |
| Homo sapiens |
K562 |
IC50 |
2.6 |
nM |
10.1021/np070332i |
| Homo sapiens |
K562 |
IC50 |
7.06 |
nM |
10.1021/jm980682p |
| Homo sapiens |
K562 |
IC50 |
133.5 |
nM |
10.1021/jm980682p |
| Homo sapiens |
K562 |
IC50 |
140.0 |
nM |
10.1016/j.bmcl.2022.128919 |
| Homo sapiens |
K562 |
IC50 |
420.0 |
nM |
10.1016/j.bmc.2008.01.033 |
| Homo sapiens |
K562 |
IC50 |
510.0 |
nM |
10.1021/jm300515q |
| Homo sapiens |
K562 |
IC50 |
2350.0 |
nM |
10.1016/j.bmc.2020.115868 |
| Homo sapiens |
K562 |
IC50 |
4550.0 |
nM |
10.1016/j.ejmech.2018.01.074 |
| Homo sapiens |
K562 |
Ratio IC50 |
4.2 |
None |
10.1016/j.bmc.2008.01.033 |
| Homo sapiens |
K562 |
Ratio IC50 |
5.1 |
None |
10.1021/jm300515q |
| Homo sapiens |
K562 |
Ratio IC50 |
10.0 |
None |
10.1021/jm300515q |
| Homo sapiens |
K562 |
Ratio IC50 |
11.0 |
None |
10.1021/jm200764t |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
2700.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KM12 |
GI50 |
220.29 |
nM |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
LoVo |
IC50 |
0.009 |
ug.mL-1 |
10.1021/jm00032a018 |
| Homo sapiens |
LoVo |
IC50 |
0.023 |
ug.mL-1 |
10.1016/s0960-894x(99)00689-7 |
| Homo sapiens |
LoVo |
IC50 |
0.024 |
ug.mL-1 |
10.1021/jm9804432 |
| Homo sapiens |
LoVo |
IC50 |
0.25 |
ug.mL-1 |
10.1021/jm00032a018 |
| Homo sapiens |
LoVo |
IC50 |
0.62 |
ug.mL-1 |
10.1016/s0960-894x(99)00689-7 |
| Homo sapiens |
LoVo |
IC50 |
0.67 |
ug.mL-1 |
10.1021/jm9804432 |
| Homo sapiens |
LoVo |
IC50 |
3.3 |
nM |
10.1021/jm049706k |
| Homo sapiens |
LoVo |
IC50 |
9.7 |
nM |
10.1021/jm00003a015 |
| Homo sapiens |
LoVo |
IC50 |
17.1 |
nM |
10.1021/jm980682p |
| Homo sapiens |
LoVo |
IC50 |
46.0 |
nM |
10.1021/jm9805586 |
| Homo sapiens |
LoVo |
IC50 |
461.0 |
nM |
10.1021/jm980682p |
| Homo sapiens |
LoVo |
IC50 |
530.0 |
nM |
10.1021/jm00003a015 |
| Homo sapiens |
LoVo |
IC50 |
1290.0 |
nM |
10.1021/jm9805586 |
| Homo sapiens |
LoVo |
IC50 |
nan |
None |
10.1016/j.bmcl.2012.08.032 |
| Homo sapiens |
LoVo |
RI |
28.0 |
None |
10.1021/jm9804432 |
| Homo sapiens |
LoVo |
RI |
28.0 |
None |
10.1021/jm9805586 |
| Homo sapiens |
LOX IMVI |
GI50 |
21.38 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4A |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
182.81 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
155.6 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
MCF7 |
GI50 |
3930.0 |
nM |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
MCF7 |
IC50 |
5.0 |
nM |
10.1021/jm00101a001 |
| Homo sapiens |
MCF7 |
IC50 |
8.7 |
nM |
10.1021/jm950742g |
| Homo sapiens |
MCF7 |
IC50 |
8.7 |
nM |
10.1021/jm960623g |
| Homo sapiens |
MCF7 |
IC50 |
9.0 |
nM |
10.1021/jm9905817 |
| Homo sapiens |
MCF7 |
IC50 |
20.0 |
nM |
10.1021/jm00003a015 |
| Homo sapiens |
MCF7 |
IC50 |
26.0 |
nM |
10.1021/jm501180v |
| Homo sapiens |
MCF7 |
IC50 |
41.0 |
nM |
10.1021/jm950742g |
| Homo sapiens |
MCF7 |
IC50 |
41.0 |
nM |
10.1021/jm960623g |
| Homo sapiens |
MCF7 |
IC50 |
41.0 |
nM |
10.1021/jm9905817 |
| Homo sapiens |
MCF7 |
IC50 |
72.0 |
nM |
10.1021/jm950742g |
| Homo sapiens |
MCF7 |
IC50 |
72.0 |
nM |
10.1021/jm960623g |
| Homo sapiens |
MCF7 |
IC50 |
72.0 |
nM |
10.1021/jm9905817 |
| Homo sapiens |
MCF7 |
IC50 |
380.2 |
nM |
10.1016/j.ejmech.2019.03.051 |
| Homo sapiens |
MCF7 |
IC50 |
4000.0 |
nM |
10.1021/jm00101a001 |
| Homo sapiens |
MCF7 |
IC50 |
7100.0 |
nM |
10.1016/j.bmc.2011.03.009 |
| Homo sapiens |
MCF7 |
IC50 |
7100.0 |
nM |
10.1016/j.bmcl.2009.06.097 |
| Homo sapiens |
MCF7 |
Inhibition |
19.0 |
% |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
MDA-MB-231 |
GI50 |
196.34 |
nM |
None |
| Homo sapiens |
MDA-MB-231 |
IC50 |
960.0 |
nM |
10.1016/j.bmc.2007.03.003 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
960.0 |
nM |
10.1021/jm061410m |
| Homo sapiens |
MDA-MB-231 |
IC50 |
1000.0 |
nM |
10.1021/jm011117g |
| Homo sapiens |
MDA-MB-435 |
GI50 |
258.82 |
nM |
None |
| Homo sapiens |
MDA-MB-435 |
IC50 |
0.35 |
nM |
10.1021/jm060593+ |
| Homo sapiens |
MDA-MB-435 |
IC50 |
646.0 |
nM |
10.1021/jm060593+ |
| Homo sapiens |
MDA-MB-435 |
IC50 |
1442.0 |
nM |
10.1021/jm060593+ |
| Homo sapiens |
MDA-MB-435 |
IC50 |
nan |
None |
10.1021/jm060593+ |
| Homo sapiens |
MDA-MB-435 |
Ratio IC50 |
2.2 |
None |
10.1021/jm060593+ |
| Homo sapiens |
MDA-N |
GI50 |
260.02 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
13399.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
11500.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
MES-SA |
IC50 |
3.0 |
nM |
10.1016/j.bmcl.2005.07.079 |
| Homo sapiens |
MES-SA |
IC50 |
3.0 |
nM |
10.1016/j.bmcl.2006.06.074 |
| Homo sapiens |
MES-SA |
IC50 |
30.0 |
nM |
10.1016/j.bmcl.2005.07.079 |
| Homo sapiens |
MES-SA |
Ratio IC50 |
6.67 |
None |
10.1016/j.bmcl.2011.03.021 |
| Homo sapiens |
MES-SA |
Ratio IC50 |
12.17 |
None |
10.1016/j.bmcl.2015.04.093 |
| Homo sapiens |
MES-SA |
RF |
11.55 |
None |
10.1016/j.bmcl.2005.07.079 |
| Homo sapiens |
MES-SA/Dx5 |
IC50 |
28.0 |
nM |
10.1016/j.bmcl.2006.06.074 |
| Homo sapiens |
MES-SA/Dx5 |
Ratio IC50 |
9.3 |
None |
10.1016/j.bmcl.2006.06.074 |
| Homo sapiens |
MKN-28 |
IC50 |
0.02 |
ug.mL-1 |
10.1021/np9903705 |
| Homo sapiens |
MKN-45 |
IC50 |
12.0 |
nM |
10.1021/jm049706k |
| Homo sapiens |
MOLT-4 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
1584.9 |
nM |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
6701.6 |
nM |
None |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
190.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
400.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
530.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 2 |
IC50 |
530.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 2 |
IC50 |
830.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
10.1124/mol.105.017988 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
IC50 |
1.5 |
nM |
10.1124/mol.105.017988 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
IC50 |
1.9 |
nM |
10.1124/mol.105.017988 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
IC50 |
27.5 |
nM |
10.1021/acs.jmedchem.9b00963 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
748.7 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
180.3 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
219.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
77.9 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
644.1 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
89.8 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
878.4 |
nM |
None |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
9856.2 |
nM |
None |
| Homo sapiens |
MV4-11 |
Activity |
nan |
None |
10.1021/jm400045y |
| Homo sapiens |
MX1 |
TWI |
57.0 |
% |
10.1021/jm9804432 |
| Homo sapiens |
N592 |
IC50 |
20.0 |
nM |
10.1021/jm00077a016 |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
1406.05 |
nM |
None |
| Homo sapiens |
NCI-H226 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
17.18 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
345.14 |
nM |
None |
| Homo sapiens |
NCI-H460 |
EC50 |
0.1224 |
ug.mL-1 |
10.1016/j.bmcl.2011.03.013 |
| Homo sapiens |
NCI-H460 |
EC50 |
30.0 |
nM |
10.1016/j.bmcl.2013.08.021 |
| Homo sapiens |
NCI-H460 |
EC50 |
120.0 |
nM |
10.1016/j.bmcl.2013.01.022 |
| Homo sapiens |
NCI-H460 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
1290.0 |
nM |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
NCI-H460 |
IC50 |
360.0 |
nM |
10.1016/j.ejmech.2019.06.066 |
| Homo sapiens |
NCI-H460 |
Inhibition |
8.0 |
% |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
NCI-H522 |
GI50 |
23.17 |
nM |
None |
| Homo sapiens |
NEDD8 activating enzyme |
Activity |
15.0 |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
NEDD8 activating enzyme |
EC50 |
1300.0 |
nM |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
NEDD8 activating enzyme |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
NEDD8/Cullin-1 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.111848 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
115820.8 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
11817.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
4989.8 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
4948.5 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
8199.5 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
14581.0 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
GI50 |
360.58 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
IC50 |
5.8 |
nM |
10.1021/jm00006a018 |
| Homo sapiens |
OVCAR-3 |
IC50 |
5.8 |
nM |
10.1021/jm950742g |
| Homo sapiens |
OVCAR-3 |
IC50 |
5.8 |
nM |
10.1021/jm960623g |
| Homo sapiens |
OVCAR-3 |
IC50 |
6.0 |
nM |
10.1021/jm9905817 |
| Homo sapiens |
OVCAR-4 |
GI50 |
344.35 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
83.56 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
25.47 |
nM |
None |
| Homo sapiens |
PC-3 |
GI50 |
124.74 |
nM |
None |
| Homo sapiens |
PC-3 |
GI50 |
780.0 |
nM |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
PC-3 |
IC50 |
7.0 |
nM |
10.1021/jm049706k |
| Homo sapiens |
PC-3 |
IC50 |
7.1 |
nM |
10.1021/jm980682p |
| Homo sapiens |
PC-3 |
IC50 |
290.0 |
nM |
10.1016/j.ejmech.2011.10.059 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/s0928-0987(03)00204-5 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
1501.0 |
nM |
10.1021/acs.jmedchem.9b00963 |
| Homo sapiens |
P-glycoprotein 1 |
% maximum response |
2.89 |
% |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
1.91 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
6.44 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_ATPase activity |
0.85 |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_Papp |
3.38 |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
70.8 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Proto-oncogene tyrosine-protein kinase ROS |
IC50 |
2998.7 |
nM |
10.1039/C6MD00643D |
| Homo sapiens |
Proto-oncogene tyrosine-protein kinase ROS |
Inhibition |
nan |
% |
10.1039/C6MD00643D |
| Homo sapiens |
Purinergic receptor P2Y12 |
Inhibition |
-11.0 |
% |
10.1021/jm9003297 |
| Homo sapiens |
Purinergic receptor P2Y12 |
Ki |
10000.0 |
nM |
10.1021/jm9003297 |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Rac GTPase-activating protein 1 |
IC50 |
14460.0 |
nM |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
91999.7 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
2035.2 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
11917.3 |
nM |
None |
| Homo sapiens |
RPMI-8226 |
GI50 |
20.04 |
nM |
None |
| Homo sapiens |
RPMI-8226 |
IC50 |
30.0 |
nM |
10.1021/jm00101a001 |
| Homo sapiens |
RPMI-8226 |
IC50 |
180.0 |
nM |
10.1021/jm00101a001 |
| Homo sapiens |
RXF 393 |
GI50 |
41.59 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Activity |
108.7 |
% |
10.1021/jm400045y |
| Homo sapiens |
Serine/threonine-protein kinase Chk2 |
Activity |
59.7 |
% |
10.1021/jm400045y |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
146.9 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase PIM1 |
Activity |
0.86 |
% |
10.1021/jm400045y |
| Homo sapiens |
Serine/threonine-protein kinase PIM1 |
Inhibition |
nan |
% |
10.1021/jm400045y |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
7110.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
3561.9 |
nM |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
1865.7 |
nM |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SF-268 |
EC50 |
0.315 |
ug.mL-1 |
10.1016/j.bmcl.2011.03.013 |
| Homo sapiens |
SF-268 |
EC50 |
320.0 |
nM |
10.1016/j.bmcl.2013.01.022 |
| Homo sapiens |
SF-268 |
GI50 |
13.58 |
nM |
None |
| Homo sapiens |
SF-268 |
GI50 |
970.0 |
nM |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
SF-268 |
Inhibition |
2.0 |
% |
10.1016/j.bmc.2007.10.012 |
| Homo sapiens |
SF-295 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
SF-539 |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
SGC-7901 |
IC50 |
0.293 |
nM |
10.1021/acs.jnatprod.8b00482 |
| Homo sapiens |
SH-SY5Y |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-BR-3 |
IC50 |
16.0 |
nM |
10.1021/jm00006a024 |
| Homo sapiens |
SK-MEL-2 |
GI50 |
209.41 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
322.11 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
71.94 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
EC50 |
0.1207 |
ug.mL-1 |
10.1016/j.bmcl.2011.03.013 |
| Homo sapiens |
SK-OV-3 |
EC50 |
120.0 |
nM |
10.1016/j.bmcl.2013.01.022 |
| Homo sapiens |
SK-OV-3 |
EC50 |
nan |
None |
10.1016/j.bmcl.2013.08.021 |
| Homo sapiens |
SK-OV-3 |
GI50 |
24.55 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
11000.0 |
nM |
10.1016/j.bmcl.2010.01.096 |
| Homo sapiens |
SK-OV-3 |
IC50 |
5.3 |
nM |
10.1016/0960-894X(96)00130-8 |
| Homo sapiens |
SK-OV-3 |
IC50 |
5.3 |
nM |
10.1021/jm970114u |
| Homo sapiens |
SK-OV-3 |
IC50 |
5.3 |
nM |
10.1021/jm9801105 |
| Homo sapiens |
SK-OV-3 |
IC50 |
9800.0 |
nM |
10.1016/j.bmcl.2009.06.097 |
| Homo sapiens |
SMMC-7721 |
Inhibition |
20.5 |
% |
10.1016/j.ejmech.2016.04.031 |
| Homo sapiens |
SMMC-7721 |
Inhibition |
62.2 |
% |
10.1016/j.ejmech.2016.04.031 |
| Homo sapiens |
SN12C |
GI50 |
13.34 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
24.04 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
13.06 |
nM |
None |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
43900.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier family 22 member 2 |
IC50 |
73300.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier family 22 member 3 |
IC50 |
60500.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
18.9 |
% |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
27.2 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
IC50 |
3390.0 |
nM |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
67.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
84.4 |
% |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Ki |
3100.0 |
nM |
10.1016/j.ejmech.2015.01.011 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
48.3 |
% |
10.1021/jm300212s |
| Homo sapiens |
SR |
GI50 |
10.0 |
nM |
None |
| Homo sapiens |
SUMO-activating enzyme |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
SW-620 |
GI50 |
93.76 |
nM |
None |
| Homo sapiens |
T47D |
GI50 |
46.56 |
nM |
None |
| Homo sapiens |
TAR DNA-binding protein 43 |
IC50 |
10000.0 |
nM |
10.1016/j.bmcl.2019.126942 |
| Homo sapiens |
Telomerase reverse transcriptase |
Activity |
7.0 |
% |
10.1016/j.ejmech.2013.06.058 |
| Homo sapiens |
Telomerase reverse transcriptase |
Activity |
10.0 |
% |
10.1016/j.ejmech.2013.06.058 |
| Homo sapiens |
Telomerase reverse transcriptase |
Activity |
21.0 |
% |
10.1016/j.ejmech.2013.06.058 |
| Homo sapiens |
Thrombopoietin |
Potency |
25.1 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
TK-10 |
GI50 |
239.88 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase BTK |
Activity |
45.9 |
% |
10.1021/jm400045y |
| Homo sapiens |
Tyrosine-protein kinase BTK |
IC50 |
1000.0 |
nM |
10.1021/jm400045y |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
1257.9 |
nM |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase YES |
Potency |
34499.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
32.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
183.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
10.79 |
nM |
None |
| Homo sapiens |
U2OS |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c01654 |
| Homo sapiens |
U-937 |
IC50 |
6200.0 |
nM |
10.1016/j.bmcl.2009.06.097 |
| Homo sapiens |
UACC-257 |
GI50 |
995.41 |
nM |
None |
| Homo sapiens |
UACC-375 |
IC50 |
48.0 |
nM |
10.1021/jm00006a018 |
| Homo sapiens |
UACC-375 |
IC50 |
48.0 |
nM |
10.1021/jm950742g |
| Homo sapiens |
UACC-375 |
IC50 |
48.0 |
nM |
10.1021/jm960623g |
| Homo sapiens |
UACC-375 |
IC50 |
48.0 |
nM |
10.1021/jm9905817 |
| Homo sapiens |
UACC-62 |
GI50 |
17.22 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
14689.2 |
nM |
None |
| Homo sapiens |
Ubiquitin-like modifier-activating enzyme 1 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.11.101 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UO-31 |
GI50 |
102.33 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Voltage-gated L-type calcium channel |
IC50 |
22500.0 |
nM |
10.1038/srep02100 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Werner syndrome ATP-dependent helicase |
Potency |
961.4 |
nM |
None |
| Homo sapiens |
Werner syndrome ATP-dependent helicase |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
WiDr |
IC50 |
8.0 |
nM |
10.1021/jm9905817 |
| Homo sapiens |
WiDr |
IC50 |
8.1 |
nM |
10.1021/jm950742g |
| Homo sapiens |
WiDr |
IC50 |
8.1 |
nM |
10.1021/jm960623g |
| Homo sapiens |
WiDr |
IC50 |
10.0 |
nM |
10.1021/jm00006a018 |
| Homo sapiens |
WiDr |
IC50 |
488.0 |
nM |
10.1021/jm950742g |
| Homo sapiens |
WiDr |
IC50 |
488.0 |
nM |
10.1021/jm960623g |
| Homo sapiens |
WiDr |
IC50 |
488.0 |
nM |
10.1021/jm9905817 |
| Homo sapiens |
WiDr |
IC50 |
1400.0 |
nM |
10.1021/jm00006a018 |
| Human immunodeficiency virus 1 |
Aberrant vpr protein |
Potency |
11220.2 |
nM |
None |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
23100.0 |
nM |
10.1021/acs.jmedchem.1c00154 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 integrase |
IC50 |
3800.0 |
nM |
10.1021/jm990322h |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 integrase |
IC50 |
8000.0 |
nM |
10.1021/jm990322h |
| Influenza A virus |
Nonstructural protein 1 |
IC50 |
2049.0 |
nM |
None |
| Leishmania major |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase |
Potency |
23934.1 |
nM |
None |
| Leishmania mexicana |
Pyruvate kinase |
Potency |
15848.9 |
nM |
None |
| Mus musculus |
4T1 |
Activity |
77.86 |
% |
10.1016/j.ejmech.2022.114375 |
| Mus musculus |
4T1 |
Activity |
93.24 |
% |
10.1016/j.ejmech.2022.114375 |
| Mus musculus |
4T1 |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114375 |
| Mus musculus |
4T1 |
T/C |
32.0 |
% |
10.1016/j.ejmech.2022.114375 |
| Mus musculus |
4T1 |
TGI |
59.8 |
% |
10.1016/j.ejmech.2022.114375 |
| Mus musculus |
4T1.2 |
GI |
nan |
None |
10.1021/acsmedchemlett.7b00090 |
| Mus musculus |
4T1.2 |
Survival |
26.0 |
day |
10.1021/acsmedchemlett.7b00090 |
| Mus musculus |
4T1.2 |
Survival |
60.0 |
% |
10.1021/acsmedchemlett.7b00090 |
| Mus musculus |
4T1.2 |
TGI |
nan |
None |
10.1021/acsmedchemlett.7b00090 |
| Mus musculus |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
None |
| Mus musculus |
B16 |
Activity |
nan |
None |
10.1021/jm00191a008 |
| Mus musculus |
B16 |
ILS |
120.0 |
% |
10.1021/jm00195a002 |
| Mus musculus |
B16 |
Optimal dose |
0.6 |
mg kg-1 |
10.1021/jm00384a021 |
| Mus musculus |
B16 |
T/C |
186.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
B16 |
T/C |
231.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
B16 |
T/C |
265.0 |
% |
10.1021/jm00384a021 |
| Mus musculus |
B16 |
T/C |
299.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
B16 |
T/C |
342.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
B16 |
T/C |
466.0 |
% |
10.1021/jm00201a012 |
| Mus musculus |
B16 |
T/C |
503.0 |
% |
10.1021/jm00201a012 |
| Mus musculus |
B16 |
TGI |
130.0 |
% |
10.1021/jm950742g |
| Mus musculus |
CCRF S-180 |
RTW |
73.0 |
% |
10.1021/jm00399a028 |
| Mus musculus |
CCRF S-180 |
RTW |
nan |
None |
10.1021/jm00399a028 |
| Mus musculus |
CCRF S-180 |
TFS |
0.0 |
% |
10.1021/jm00399a028 |
| Mus musculus |
CCRF S-180 |
Toxic deaths |
0.0 |
None |
10.1021/jm00399a028 |
| Mus musculus |
Colon 26 |
Activity |
nan |
None |
10.1021/jm00191a008 |
| Mus musculus |
Colon 26 |
T/C |
259.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
Colon 26 |
T/C |
305.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
Colon 26 |
T/C |
353.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
H22 |
Activity |
0.57 |
g |
10.1016/j.ejmech.2016.04.031 |
| Mus musculus |
H22 |
Activity |
9.0 |
nM |
10.1016/j.ejmech.2019.03.051 |
| Mus musculus |
H22 |
Activity |
29.1 |
None |
10.1016/j.ejmech.2016.04.031 |
| Mus musculus |
H22 |
Activity |
nan |
None |
10.1016/j.ejmech.2019.03.051 |
| Mus musculus |
H22 |
IC50 |
187.0 |
nM |
10.1016/j.ejmech.2019.03.051 |
| Mus musculus |
H22 |
Inhibition |
49.2 |
% |
10.1016/j.ejmech.2016.04.031 |
| Mus musculus |
H22 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.03.051 |
| Mus musculus |
H22 |
TGI |
73.4 |
% |
10.1016/j.ejmech.2016.04.031 |
| Mus musculus |
L1210 |
Activity |
nan |
None |
10.1021/jm00191a008 |
| Mus musculus |
L1210 |
EC50 |
5.0 |
ug.mL-1 |
10.1021/jm00118a015 |
| Mus musculus |
L1210 |
IC50 |
0.009 |
ug.mL-1 |
10.1021/jm00032a018 |
| Mus musculus |
L1210 |
IC50 |
0.04 |
nM |
10.1021/jm970114u |
| Mus musculus |
L1210 |
IC50 |
1.6 |
nM |
10.1021/jm00384a021 |
| Mus musculus |
L1210 |
IC50 |
1.6 |
nM |
10.1021/jm00403a009 |
| Mus musculus |
L1210 |
IC50 |
2.0 |
nM |
10.1021/jm00086a010 |
| Mus musculus |
L1210 |
IC50 |
5.0 |
nM |
10.1021/jm00006a018 |
| Mus musculus |
L1210 |
IC50 |
9.7 |
nM |
10.1021/jm950742g |
| Mus musculus |
L1210 |
IC50 |
9.7 |
nM |
10.1021/jm960623g |
| Mus musculus |
L1210 |
IC50 |
10.0 |
nM |
10.1021/jm9905817 |
| Mus musculus |
L1210 |
IC50 |
11.4 |
nM |
10.1021/jm980682p |
| Mus musculus |
L1210 |
IC50 |
39.0 |
nM |
10.1021/jm00006a018 |
| Mus musculus |
L1210 |
IC50 |
39.0 |
nM |
10.1021/jm950742g |
| Mus musculus |
L1210 |
IC50 |
39.0 |
nM |
10.1021/jm960623g |
| Mus musculus |
L1210 |
IC50 |
39.0 |
nM |
10.1021/jm9905817 |
| Mus musculus |
L1210 |
IC50 |
40.0 |
nM |
10.1016/s0960-894x(02)00218-4 |
| Mus musculus |
L1210 |
IC50 |
77.0 |
nM |
10.1016/j.bmcl.2005.07.079 |
| Mus musculus |
L1210 |
IC50 |
100.0 |
nM |
10.1016/j.bmcl.2004.07.036 |
| Mus musculus |
L1210 |
IC50 |
100.0 |
nM |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
IC50 |
15000.0 |
nM |
10.1016/j.ejmech.2017.02.013 |
| Mus musculus |
L1210 |
ID50 |
1.55 |
M |
10.1021/jm00369a002 |
| Mus musculus |
L1210 |
ILS |
73.0 |
% |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
ILS |
105.0 |
% |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
ILS |
150.0 |
% |
10.1021/jm950742g |
| Mus musculus |
L1210 |
Mean |
16.7 |
None |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
Mean |
17.3 |
None |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
Net log cell kill |
6.8 |
None |
10.1021/jm00403a009 |
| Mus musculus |
L1210 |
Range |
15.0 |
None |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
T/C |
163.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
L1210 |
T/C |
198.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
L1210 |
T/C |
256.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
L1210 |
T/C |
261.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
L1210 |
T/C |
308.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
L1210 |
TFS |
0.0 |
None |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
TFS |
7.0 |
None |
10.1021/jm00399a028 |
| Mus musculus |
L1210 |
Toxic deaths |
0.0 |
None |
10.1021/jm00399a028 |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Mus musculus |
Activity |
-2.3 |
g |
10.1021/jm00201a012 |
| Mus musculus |
Mus musculus |
Activity |
-2.0 |
g |
10.1021/jm00201a012 |
| Mus musculus |
Mus musculus |
Activity |
-1.7 |
g |
10.1021/jm00201a012 |
| Mus musculus |
Mus musculus |
Activity |
-1.4 |
g |
10.1021/jm00201a012 |
| Mus musculus |
Mus musculus |
Activity |
-0.6 |
g |
10.1021/jm00201a012 |
| Mus musculus |
Mus musculus |
Activity |
15.0 |
% |
10.1021/acsmedchemlett.7b00090 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114375 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acsmedchemlett.7b00090 |
| Mus musculus |
Mus musculus |
Body weight change |
0.98 |
BWC |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
Body weight change |
1.02 |
BWC |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
Body weight change |
1.05 |
BWC |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
Cures |
0.0 |
None |
10.1021/jm020420u |
| Mus musculus |
Mus musculus |
DOSE |
0.6 |
mg.kg-1 |
10.1021/jm00403a009 |
| Mus musculus |
Mus musculus |
Growth delay |
2.0 |
day |
10.1021/jm020420u |
| Mus musculus |
Mus musculus |
ID50 |
7e-09 |
M |
10.1021/jm00067a005 |
| Mus musculus |
Mus musculus |
ILS |
200.0 |
% |
10.1021/jm00006a018 |
| Mus musculus |
Mus musculus |
ILS |
200.0 |
% |
10.1021/jm960623g |
| Mus musculus |
Mus musculus |
LD10 |
2.0 |
mg kg-1 day-1 |
10.1021/jm00032a018 |
| Mus musculus |
Mus musculus |
LD10 |
3.0 |
mg kg-1 day-1 |
10.1021/jm00032a018 |
| Mus musculus |
Mus musculus |
LD10 |
4.0 |
mg kg-1 day-1 |
10.1021/jm00032a018 |
| Mus musculus |
Mus musculus |
LD50 |
7e-09 |
M |
10.1021/jm00067a005 |
| Mus musculus |
Mus musculus |
LTS |
0.0 |
None |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
T/C |
196.0 |
% |
10.1021/jm00032a018 |
| Mus musculus |
Mus musculus |
T/C |
265.0 |
% |
10.1021/jm00403a009 |
| Mus musculus |
Mus musculus |
T/C (ratio of treated to control) |
158.0 |
% |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
T/C (ratio of treated to control) |
173.0 |
% |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
T/C (ratio of treated to control) |
174.0 |
% |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
T/C (ratio of treated to control) |
229.0 |
% |
10.1021/jm980682p |
| Mus musculus |
Mus musculus |
Toxic deaths |
0.0 |
None |
10.1021/jm00032a018 |
| Mus musculus |
Mus musculus |
Toxic deaths |
12.0 |
None |
10.1021/jm00032a018 |
| Mus musculus |
Mus musculus |
Toxic deaths |
43.0 |
None |
10.1021/jm00032a018 |
| Mus musculus |
NIH3T3 |
IC50 |
42000.0 |
nM |
10.1016/j.ejmech.2017.02.013 |
| Mus musculus |
NIH3T3 |
IC50 |
nan |
None |
10.1007/s00044-012-0325-2 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
P388 |
Activity |
6.8 |
None |
10.1021/jm00384a021 |
| Mus musculus |
P388 |
Activity |
nan |
None |
10.1021/jm00191a008 |
| Mus musculus |
P388 |
Activity |
nan |
None |
10.1021/jm00201a012 |
| Mus musculus |
P388 |
DOSE |
1.25 |
mg.kg-1 |
10.1021/jm00403a009 |
| Mus musculus |
P388 |
DOSE |
3.0 |
mg.kg-1 |
10.1021/jm00384a021 |
| Mus musculus |
P388 |
IC50 |
4.3 |
nM |
10.1021/jm060593+ |
| Mus musculus |
P388 |
IC50 |
27560.0 |
nM |
10.1021/jm980324m |
| Mus musculus |
P388 |
IC90 |
38700.0 |
nM |
10.1021/jm980324m |
| Mus musculus |
P388 |
ILS |
200.0 |
% |
10.1021/jm950742g |
| Mus musculus |
P388 |
ILS |
278.0 |
% |
10.1021/jm00195a002 |
| Mus musculus |
P388 |
Ratio IC50 |
2.0 |
None |
10.1021/jm060593+ |
| Mus musculus |
P388 |
T/C |
118.0 |
% |
10.1021/jm00128a009 |
| Mus musculus |
P388 |
T/C |
138.0 |
% |
10.1021/jm00032a018 |
| Mus musculus |
P388 |
T/C |
172.0 |
% |
10.1021/jm00032a018 |
| Mus musculus |
P388 |
T/C |
192.0 |
% |
10.1021/jm00128a009 |
| Mus musculus |
P388 |
T/C |
192.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
P388 |
T/C |
197.0 |
% |
10.1021/jm9804432 |
| Mus musculus |
P388 |
T/C |
200.0 |
% |
10.1021/jm00201a012 |
| Mus musculus |
P388 |
T/C |
200.0 |
None |
10.1021/jm00392a028 |
| Mus musculus |
P388 |
T/C |
201.0 |
% |
10.1021/jm00128a009 |
| Mus musculus |
P388 |
T/C |
208.0 |
% |
10.1021/jm00201a012 |
| Mus musculus |
P388 |
T/C |
208.0 |
None |
10.1021/jm00392a028 |
| Mus musculus |
P388 |
T/C |
209.0 |
% |
10.1021/jm00128a009 |
| Mus musculus |
P388 |
T/C |
210.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
P388 |
T/C |
224.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
P388 |
T/C |
230.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
P388 |
T/C |
231.0 |
% |
10.1021/jm00369a002 |
| Mus musculus |
P388 |
T/C |
267.0 |
% |
10.1021/jm00384a021 |
| Mus musculus |
P388 |
T/C |
277.0 |
% |
10.1021/jm00201a012 |
| Mus musculus |
P388 |
T/C |
277.0 |
None |
10.1021/jm00392a028 |
| Mus musculus |
P388 |
T/C |
278.0 |
% |
10.1021/jm00369a002 |
| Mus musculus |
P388 |
T/C |
280.0 |
% |
10.1021/jm00201a012 |
| Mus musculus |
P388 |
T/C |
280.0 |
None |
10.1021/jm00392a028 |
| Mus musculus |
P388 |
T/C |
288.0 |
% |
10.1021/jm00128a009 |
| Mus musculus |
P388 |
T/C |
291.0 |
% |
10.1021/jm00403a009 |
| Mus musculus |
P388 |
T/C |
299.0 |
% |
10.1021/jm00201a012 |
| Mus musculus |
P388 |
T/C |
299.0 |
None |
10.1021/jm00392a028 |
| Mus musculus |
P388 |
T/C |
305.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
P388 |
T/C |
381.0 |
% |
10.1021/jm00191a008 |
| Mus musculus |
P388/ADR |
IC50 |
194.0 |
nM |
10.1021/jm060593+ |
| Mus musculus |
P388/ADR |
IC50 |
395.0 |
nM |
10.1021/jm060593+ |
| Mus musculus |
P388/ADR |
IC50 |
nan |
None |
10.1021/jm060593+ |
| Mus musculus |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/s0006-2952(96)00512-6 |
| Mus musculus |
Transient receptor potential cation channel subfamily M member 7 |
Inhibition |
nan |
% |
None |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
Activity |
nan |
None |
10.1016/j.ejmech.2019.05.081 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
IC50 |
5020.0 |
nM |
10.1128/aac.00803-09 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
IC50 |
9700.0 |
nM |
10.1128/aac.00803-09 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
IC50 |
21840.0 |
nM |
10.1128/aac.00803-09 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
50000.0 |
nM |
10.1128/aac.00803-09 |
| Oncorhynchus gorbuscha |
Salmon testes DNA |
AC50 |
2316.0 |
nM |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
1785.3 |
nM |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
0.59 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
0.83 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
0.93 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1.0 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1.12 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1.41 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1.48 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
630.96 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
794.33 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1000.0 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1258.93 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1584.89 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1613.7 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2869.5 |
nM |
None |
| Pseudomonas aeruginosa |
Beta Lactamase |
IC50 |
630.0 |
nM |
None |
| Pseudomonas aeruginosa |
Beta Lactamase |
IC50 |
56000.0 |
nM |
None |
| Pseudomonas aeruginosa |
Beta Lactamase |
Ki |
1500.0 |
nM |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Brain |
Compound recovery |
nan |
None |
10.1124/dmd.110.035998 |
| Rattus norvegicus |
Brain |
Fu |
0.0046 |
None |
10.1124/dmd.110.035998 |
| Rattus norvegicus |
Brain |
Kp |
8.01 |
None |
10.1124/dmd.110.035998 |
| Rattus norvegicus |
Brain |
Vd |
1757.0 |
L.kg-1 |
10.1124/dmd.110.035998 |
| Rattus norvegicus |
C6 |
Activity |
nan |
None |
10.1021/np960144k |
| Rattus norvegicus |
C6 |
IC50 |
10.9 |
ug.mL-1 |
10.1007/s00044-012-0325-2 |
| Rattus norvegicus |
C6 |
IC50 |
11.0 |
ug.mL-1 |
10.1016/j.ejmech.2015.11.002 |
| Rattus norvegicus |
C6 |
Inhibition |
84.6 |
% |
10.1007/s00044-012-0325-2 |
| Rattus norvegicus |
C6 |
Inhibition |
nan |
% |
10.1007/s00044-012-0325-2 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A |
AC50 |
1248.0 |
nM |
None |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10805.6 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
10000.0 |
nM |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Multidrug resistance protein 1 |
Activity |
nan |
None |
10.1016/s0006-2952(96)00512-6 |
| Rattus norvegicus |
Multidrug resistance protein 1a |
Activity |
nan |
None |
10.1016/s0006-2952(96)00512-6 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
5011.9 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
17782.8 |
nM |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
346.4 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
424.8 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
7737.0 |
None |
10.1021/jm950742g |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
33700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
44300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
45000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
255.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
328.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
370.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
444.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
32.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
42.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
42.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
46.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
47.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
64.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
67.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
75.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
143.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
156.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Cardiotoxicity |
7737.0 |
None |
10.1021/jm960623g |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
104.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
105.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
107.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
773.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
776.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
793.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
1070.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
192.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
193.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
220.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
271.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
23000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
29330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.4 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
26.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
34.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1423.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1630.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1633.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1803.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
32.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.13 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.37 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.23 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
125000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
128300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
128700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
133700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
101.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
141.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
145.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
207.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
12.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
1225.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
1529.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
5180.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
7414.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
91.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
94.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
96.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
99.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.07 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.37 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.9 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.47 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
373700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
377300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
379700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
381000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.73 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.87 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.87 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
64.27 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
42.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
92.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
2.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
4.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
8.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
137.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
217.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
224.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
117.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
119.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
122.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
135.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
946000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1484000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1537000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1671330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.98 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.53 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.74 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
7.01 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
52000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
62300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5120000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5380000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5520000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5820000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.33 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
145.1 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.2 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.57 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.7 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
13.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
26.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
26.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
1230.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
1670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
5470.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
7770.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
4779.8 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
IZ |
2.0 |
mm |
10.1016/j.ejmech.2010.07.050 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
IZ |
3.0 |
mm |
10.1016/j.ejmech.2010.07.050 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
Slope |
0.01 |
mutants ug-1 |
10.1021/jm980167r |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
Slope |
3.04 |
mutants ug-1 |
10.1021/jm980167r |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
Slope |
3.52 |
mutants ug-1 |
10.1021/jm980167r |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
14.55 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.05299 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
1.28 |
% |
10.6019/CHEMBL4495565 |
| Thermus aquaticus |
Taq polymerase 1 |
Inhibition |
nan |
% |
10.1021/jm9801105 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
4775.5 |
nM |
None |
| Trypanosoma brucei brucei |
Phosphoglycerate kinase, glycosomal |
Potency |
21331.3 |
nM |
None |
| Trypanosoma brucei brucei (strain 927/4 GUTat10.1) |
Putative uncharacterized protein |
Potency |
39810.7 |
nM |
None |
| None |
ADMET |
Activity |
-6.6 |
% |
10.1016/j.ejmech.2016.04.031 |
| None |
ADMET |
Activity |
-0.8 |
% |
10.1016/j.ejmech.2016.04.031 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2015.11.002 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2016.04.031 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114375 |
| None |
ADMET |
Cardiotoxicity |
7737.0 |
nM |
10.1021/jm00006a018 |
| None |
ADMET |
Change in Tm |
15.0 |
None |
10.1016/0960-894X(96)00130-8 |
| None |
ADMET |
Change in Tm |
25.0 |
None |
10.1016/0960-894X(96)00130-8 |
| None |
ADMET |
CL |
7.9 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Compound recovery |
4.4 |
% |
None |
| None |
ADMET |
Drug uptake |
nan |
None |
10.1021/acsmedchemlett.7b00090 |
| None |
ADMET |
FA |
nan |
None |
10.1021/jm049711o |
| None |
ADMET |
GI |
59.04 |
% |
10.1007/s00044-013-0805-z |
| None |
ADMET |
IC50 |
0.75 |
nM |
10.1021/jm049706k |
| None |
ADMET |
IC50 |
0.85 |
nM |
10.1021/jm049706k |
| None |
ADMET |
IC50 |
1.0 |
nM |
10.1021/jm00048a017 |
| None |
ADMET |
IC50 |
6.8 |
nM |
10.1021/jm049706k |
| None |
ADMET |
IC50 |
12.0 |
nM |
10.1021/jm049706k |
| None |
ADMET |
IC50 |
75.0 |
nM |
10.1021/jm049706k |
| None |
ADMET |
IC50 |
100.0 |
nM |
10.1021/jm800160v |
| None |
ADMET |
IC50 |
110.0 |
nM |
10.1021/jm049706k |
| None |
ADMET |
K app |
34.0 |
M-1 |
10.1021/jm030820x |
| None |
ADMET |
log10(%HIA +10) |
1.176 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
MRT |
25.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
MTD |
0.4 |
mg kg-1 |
10.1016/j.ejmech.2016.04.031 |
| None |
ADMET |
Papp |
0.74 |
cm/s * 10E6 |
10.1021/jm049711o |
| None |
ADMET |
Papp |
2.3 |
cm/s * 10E6 |
10.1021/jm049711o |
| None |
ADMET |
Papp |
7.3 |
cm/s * 10E6 |
10.1021/jm049711o |
| None |
ADMET |
Papp |
7.9 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
12.5 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
14.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
26.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
48.0 |
cm/s * 10E6 |
10.1021/jm049711o |
| None |
ADMET |
Ratio |
-46.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
-16.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.5 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.6 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
37.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
T1/2 |
53.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T/C |
190.0 |
None |
10.1021/jm00067a005 |
| None |
ADMET |
Toxicity ratio |
387.0 |
None |
10.1021/jm00006a018 |
| None |
ADMET |
Vdss |
12.0 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Bone marrow cell |
GI50 |
7000.0 |
nM |
10.1021/acs.jmedchem.8b00813 |
| None |
DNA |
Activity |
5.0 |
% |
10.1016/j.bmc.2019.115260 |
| None |
DNA |
Activity |
nan |
None |
10.1016/j.bmc.2019.115260 |
| None |
DNA |
T1/2 |
0.42 |
hr |
10.1016/j.bmc.2019.115260 |
| None |
EBV-positive nasopharyngeal cell line |
Reduction |
67.0 |
% |
10.1021/jm00366a004 |
| None |
EBV-positive nasopharyngeal cell line |
Survival |
0.33 |
None |
10.1021/jm00366a004 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
4.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
1.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
2.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
13.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
4.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Molecular identity unknown |
Inhibition |
7.0 |
% |
10.1016/j.ejmech.2012.01.044 |
| None |
Molecular identity unknown |
Inhibition |
9.0 |
% |
10.1016/j.ejmech.2012.01.044 |
| None |
Molecular identity unknown |
Inhibition |
20.0 |
% |
10.1016/j.ejmech.2012.01.044 |
| None |
NON-PROTEIN TARGET |
Activity |
0.0 |
% |
10.1016/j.ejmech.2012.01.044 |
| None |
NON-PROTEIN TARGET |
Activity |
0.0 |
% |
10.1016/j.ejmech.2013.06.058 |
| None |
NON-PROTEIN TARGET |
Activity |
23.0 |
% |
10.1016/j.ejmech.2012.01.044 |
| None |
NON-PROTEIN TARGET |
Activity |
24.0 |
% |
10.1016/j.ejmech.2013.06.058 |
| None |
NON-PROTEIN TARGET |
Activity |
99.0 |
% |
None |
| None |
NON-PROTEIN TARGET |
CC50 |
6341.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
EC50 |
0.0865 |
ug.mL-1 |
10.1016/j.bmcl.2011.03.013 |
| None |
NON-PROTEIN TARGET |
EC50 |
0.355 |
ug.mL-1 |
10.1016/j.bmcl.2011.03.013 |
| None |
NON-PROTEIN TARGET |
EC50 |
0.7629 |
ug.mL-1 |
10.1016/j.bmcl.2011.03.013 |
| None |
NON-PROTEIN TARGET |
EC50 |
42.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
EC50 |
90.0 |
nM |
10.1016/j.bmcl.2013.01.022 |
| None |
NON-PROTEIN TARGET |
EC50 |
360.0 |
nM |
10.1016/j.bmcl.2013.01.022 |
| None |
NON-PROTEIN TARGET |
EC50 |
420.0 |
nM |
10.1016/j.bmcl.2013.08.021 |
| None |
NON-PROTEIN TARGET |
EC50 |
760.0 |
nM |
10.1016/j.bmcl.2013.01.022 |
| None |
NON-PROTEIN TARGET |
EC50 |
1100.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Fu |
0.13 |
None |
10.1021/jm401963n |
| None |
NON-PROTEIN TARGET |
Fu |
0.25 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
GI50 |
4.42 |
ug.mL-1 |
10.1021/jm9005059 |
| None |
NON-PROTEIN TARGET |
GI50 |
26.0 |
nM |
10.1016/j.bmc.2007.10.012 |
| None |
NON-PROTEIN TARGET |
GI50 |
47.86 |
nM |
10.1016/j.bmc.2008.07.069 |
| None |
NON-PROTEIN TARGET |
GI50 |
130.0 |
nM |
10.1016/j.bmc.2007.03.067 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
42.8 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
21.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
80.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
0.73 |
ug.mL-1 |
10.1016/j.ejmech.2015.11.002 |
| None |
NON-PROTEIN TARGET |
IC50 |
1.54 |
ug.mL-1 |
10.1021/np9903705 |
| None |
NON-PROTEIN TARGET |
IC50 |
6.0 |
nM |
10.1016/j.bmcl.2015.04.093 |
| None |
NON-PROTEIN TARGET |
IC50 |
10.0 |
nM |
10.1021/jm00086a010 |
| None |
NON-PROTEIN TARGET |
IC50 |
12.0 |
nM |
10.1016/j.bmcl.2011.03.021 |
| None |
NON-PROTEIN TARGET |
IC50 |
13.0 |
nM |
10.1016/j.bmcl.2015.04.093 |
| None |
NON-PROTEIN TARGET |
IC50 |
30.0 |
nM |
10.1021/jm00077a016 |
| None |
NON-PROTEIN TARGET |
IC50 |
41.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
IC50 |
73.0 |
nM |
10.1016/j.bmcl.2015.04.093 |
| None |
NON-PROTEIN TARGET |
IC50 |
80.0 |
nM |
10.1016/j.bmcl.2011.03.021 |
| None |
NON-PROTEIN TARGET |
IC50 |
435.0 |
nM |
10.1021/jm501180v |
| None |
NON-PROTEIN TARGET |
IC50 |
561.0 |
nM |
10.1016/j.bmcl.2012.08.032 |
| None |
NON-PROTEIN TARGET |
IC50 |
1510.0 |
nM |
10.1016/j.bmc.2010.08.025 |
| None |
NON-PROTEIN TARGET |
IC50 |
1510.0 |
nM |
10.1016/j.bmcl.2011.02.106 |
| None |
NON-PROTEIN TARGET |
IC50 |
1510.0 |
nM |
10.1021/jm800017u |
| None |
NON-PROTEIN TARGET |
IC50 |
1680.0 |
nM |
10.1016/j.bmc.2008.01.033 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.bmcl.2012.08.032 |
| None |
NON-PROTEIN TARGET |
LC50 |
7244.36 |
nM |
10.1016/j.bmc.2008.07.069 |
| None |
NON-PROTEIN TARGET |
Ratio |
1.2 |
None |
10.1016/j.bmcl.2003.12.015 |
| None |
NON-PROTEIN TARGET |
Ratio |
2.1 |
None |
10.1021/jm980324m |
| None |
NON-PROTEIN TARGET |
Ratio |
4.8 |
None |
10.1021/jm980324m |
| None |
NON-PROTEIN TARGET |
Ratio |
9.0 |
None |
10.1021/jm00048a017 |
| None |
NON-PROTEIN TARGET |
Ratio |
11.6 |
None |
10.1021/jm980324m |
| None |
NON-PROTEIN TARGET |
Ratio IC50 |
24.0 |
None |
10.1021/jm800017u |
| None |
NON-PROTEIN TARGET |
Resistance index |
27.0 |
None |
10.1016/s0960-894x(99)00689-7 |
| None |
NON-PROTEIN TARGET |
TGI |
691.83 |
nM |
10.1016/j.bmc.2008.07.069 |
| None |
NON-PROTEIN TARGET |
Toxicity ratio |
368.0 |
None |
10.1021/jm950742g |
| None |
No relevant target |
LogP |
-3.1 |
None |
10.1016/j.ejmech.2009.12.043 |
| None |
No relevant target |
pKa |
3.2 |
None |
10.1124/dmd.110.035998 |
| None |
No relevant target |
pKa |
7.4 |
None |
10.1021/jm00086a010 |
| None |
No relevant target |
pKa |
8.4 |
None |
10.1124/dmd.110.035998 |
| None |
Nucleic Acid |
C50 |
nan |
None |
10.1016/j.ejmech.2009.12.047 |
| None |
Nucleic Acid |
Delta Tm |
7.4 |
None |
10.1021/jm00086a010 |
| None |
Nucleic Acid |
Delta Tm |
11.7 |
None |
10.1021/jm00086a010 |
| None |
Nucleic Acid |
Delta Tm |
15.0 |
None |
10.1021/jm00086a010 |
| None |
Nucleic Acid |
Delta Tm |
15.9 |
degrees C |
10.1021/jm00067a005 |
| None |
Nucleic Acid |
Delta Tm |
23.0 |
degrees C |
10.1016/j.ejmech.2008.02.011 |
| None |
Nucleic Acid |
Delta Tm |
26.4 |
None |
10.1021/jm00086a010 |
| None |
Nucleic Acid |
EC50 |
890.0 |
nM |
10.1021/jm9013407 |
| None |
Nucleic Acid |
IC50 |
460.0 |
nM |
10.1021/jm9013407 |
| None |
Nucleic Acid |
K app |
2.4e-06 |
None |
10.1021/jm9805586 |
| None |
Nucleic Acid |
K app |
3.2e-06 |
None |
10.1021/jm9805586 |
| None |
Nucleic Acid |
K app |
3.41e-06 |
M-1 |
10.1021/jm010917o |
| None |
Nucleic Acid |
Log Kd |
nan |
None |
10.1021/jm00370a007 |
| None |
Nucleic Acid |
Q |
0.32 |
uM |
10.1021/jm970114u |
| None |
Nucleic Acid |
Q |
0.37 |
uM |
10.1021/jm970114u |
| None |
Nucleic Acid |
Tm |
91.0 |
degrees C |
10.1016/j.ejmech.2009.12.047 |
| None |
Tumor cell line |
IC50 |
27.0 |
nM |
10.1021/jm950742g |
| None |
Unchecked |
AbsAC35_uM |
2.03 |
uM |
None |
| None |
Unchecked |
AC50 |
355.0 |
nM |
None |
| None |
Unchecked |
AC50 |
374.0 |
nM |
None |
| None |
Unchecked |
AC50 |
23890.0 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2010.07.050 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/np960144k |
| None |
Unchecked |
CC50 |
380.0 |
nM |
None |
| None |
Unchecked |
GI50 |
62900.0 |
nM |
10.1021/acs.jmedchem.8b00813 |
| None |
Unchecked |
Gross kill |
0.8 |
None |
10.1021/jm00369a002 |
| None |
Unchecked |
Gross kill |
1.1 |
None |
10.1021/jm00369a002 |
| None |
Unchecked |
Hepatotoxicity (acute) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
3.0 |
nM |
10.1021/jm9905817 |
| None |
Unchecked |
IC50 |
21.0 |
nM |
10.1021/jm950742g |
| None |
Unchecked |
IC50 |
37.4 |
nM |
10.1021/acs.jmedchem.9b00963 |
| None |
Unchecked |
IC50 |
630.0 |
nM |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
IC50 |
800.0 |
nM |
10.1021/jm400045y |
| None |
Unchecked |
IC50 |
3000.0 |
nM |
10.1016/j.ejmech.2019.112008 |
| None |
Unchecked |
IC50 |
25000.0 |
nM |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
IC50 |
40600.0 |
nM |
10.1016/j.ejmech.2019.06.066 |
| None |
Unchecked |
IC50 |
56000.0 |
nM |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
IC50 |
100000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
121794.0 |
nM |
None |
| None |
Unchecked |
IC50 |
211070.0 |
nM |
None |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
Inhibition |
67.0 |
% |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
Inhibition |
75.81 |
% |
10.1016/j.ejmech.2016.04.031 |
| None |
Unchecked |
Inhibition |
82.5 |
% |
10.1016/j.ejmech.2016.04.031 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
K |
nan |
None |
10.1021/jm00048a017 |
| None |
Unchecked |
Kd |
33.0 |
nM |
10.1016/j.ejmech.2019.112008 |
| None |
Unchecked |
Kd |
33.0 |
nM |
10.1021/acsmedchemlett.3c00020 |
| None |
Unchecked |
Kd |
46.0 |
nM |
10.1016/j.ejmech.2019.112008 |
| None |
Unchecked |
Kd |
1000.0 |
nM |
10.1021/acsmedchemlett.3c00020 |
| None |
Unchecked |
Ki |
1500.0 |
nM |
10.1016/j.bmc.2009.05.070 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
100.0 |
nM |
None |
| None |
Unchecked |
Potency |
316.2 |
nM |
None |
| None |
Unchecked |
Potency |
326.3 |
nM |
None |
| None |
Unchecked |
Potency |
429.4 |
nM |
None |
| None |
Unchecked |
Potency |
1258.9 |
nM |
None |
| None |
Unchecked |
Potency |
1412.5 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
4466.8 |
nM |
None |
| None |
Unchecked |
Potency |
6793.1 |
nM |
None |
| None |
Unchecked |
Potency |
7349.5 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
12080.0 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
12995.3 |
nM |
None |
| None |
Unchecked |
Potency |
17782.8 |
nM |
None |
| None |
Unchecked |
Potency |
23109.3 |
nM |
None |
| None |
Unchecked |
Ratio |
0.26 |
None |
10.1021/jm301302s |
| None |
Unchecked |
Ratio |
0.35 |
None |
10.1021/jm301302s |
| None |
Unchecked |
Ratio |
0.73 |
None |
10.1021/jm301302s |
| None |
Unchecked |
Ratio |
9.0 |
None |
10.1021/jm00022a016 |
| None |
Unchecked |
Ratio |
28.0 |
None |
10.1021/jm00032a018 |
| None |
Unchecked |
Ratio |
50.2 |
None |
10.1021/jm00112a009 |
| None |
Unchecked |
Ratio |
nan |
None |
10.1021/jm00006a024 |
| None |
Unchecked |
Ratio IC50 |
2.8 |
None |
10.1016/j.ejmech.2017.02.013 |
| None |
Unchecked |
Ratio IC50 |
3.5 |
None |
10.1021/acs.jmedchem.9b00963 |
| None |
Unchecked |
Ratio IC50 |
37.0 |
None |
10.1016/j.bmcl.2018.06.042 |
| None |
Unchecked |
Ratio IC50 |
37.0 |
None |
10.1016/j.ejmech.2017.03.028 |
| None |
Unchecked |
Ratio IC50 |
40.1 |
None |
10.1021/acs.jmedchem.9b00963 |
| None |
Unchecked |
Ratio IC50 |
77.2 |
None |
10.1021/acs.jmedchem.9b00963 |
| None |
Unchecked |
RI |
54.6 |
None |
10.1021/jm00003a015 |
| None |
Unchecked |
Survival |
6.0 |
None |
10.1021/jm00128a009 |
| None |
Unchecked |
T-C |
3.0 |
day |
10.1021/jm00369a002 |
| None |
Unchecked |
T-C |
4.1 |
day |
10.1021/jm00369a002 |
| None |
Unchecked |
Toxicity ratio |
368.0 |
None |
10.1021/jm960623g |